NCT03233035View on ClinicalTrials.gov

Low Dose Ketamine Intra Nasal Traumatology

PHASE2CompletedINTERVENTIONAL
Enrollment

1,102

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 1, 2018

Study Completion Date

December 1, 2018

Conditions
Trauma
Interventions
DRUG

Ketamine

25mg of ketamine in 0.5 ml of serum saline in one pulverisation per nostril is received

DRUG

Placebo

0.5 mL of normal saline solution as a placebo in one pulverisation per nostril

Trial Locations (2)

5000

Nouira Samir, Monastir

Emergency department of university hospital Fattouma Bourguiba of Monastir, Monastir

All Listed Sponsors
lead

University of Monastir

OTHER

NCT03233035 - Low Dose Ketamine Intra Nasal Traumatology | Biotech Hunter | Biotech Hunter